Project #77: Protection Against Type 1 Diabetes Development by mTOR/4E-BP2 Signaling
Project #77 funds research on how mTOR/4E-BP2 signaling impacts immune responses in type 1 diabetes, aiming to reveal new targets for prevention.
Funder: Diabetes Research Connection
Due Dates: Rolling
Funding Amounts: Up to $75,000 per project; typically supports 1-year early-stage research.
Summary: Supports innovative, early-career research on immune regulation and prevention of type 1 diabetes via mTOR/4E-BP2 signaling.
Key Information: Open to early-career investigators; projects must focus on type 1 diabetes.
Description
This opportunity, offered by the Diabetes Research Connection, funds early-career scientists investigating novel mechanisms and therapeutic strategies for type 1 diabetes (T1D). The featured project explores how the mTOR/4E-BP2 signaling pathway influences immune cell behavior related to the onset and progression of T1D. By analyzing the impact of the protein 4E-BP2 on immune cell populations using advanced single cell RNA sequencing, the research aims to identify molecular pathways, biomarkers, and potential therapeutic targets to prevent or delay immune-mediated beta cell destruction in the pancreas.
